Global Compliance · Accomplished Senior Professionals & SMEs

Global cGMP, GCP, GLP & GVP Auditing and Compliance Services

A global consortium of senior GxP professionals assisting pharmaceutical, biopharmaceutical and medical device industries to comply with GxP requirements and succeed in regulatory inspections.

⚡ Accomplished Senior Professionals & SMEs with regulator-facing experience 🧪 cGMP · GLP · GCP · GVP Compliance — standalone or integrated 🛡️ FDA · Health Canada · EMA · PMDA · MFDS | Experience with Global Regulatory Authorities
GxP
GCP
cGMP
GLP
GVP
EXPERIENCE WITH GLOBAL REGULATORY AUTHORITIES
FDA Health Canada EMA MHRA PMDA MFDS NMPA TGA CDSCO OECD EU GMP FDA Health Canada EMA MHRA PMDA MFDS NMPA TGA CDSCO OECD EU GMP
About the Consortium

Risk-based & Practical GxP Compliance Support

We are a global consortium of senior GxP professionals (with 25+ years of experience) specializing in inspection readiness, audits, and compliance strategy across cGMP, GLP, GCP & GVP. With extensive hands-on experience interacting with global regulatory authorities such as FDA, Health Canada, EMA, MHRA, PMDA, NMPA, MFDS, CDSCO etc., we help organizations prepare for a successful inspection and also assist in post-inspection interactions with the regulatory authorities.

We provide end-to-end support — from audit planning, readiness assessment, SME training, mock inspections, audits & CAPAs to CAPA closure and effectiveness verification — for pharmaceutical, biopharmaceutical, biotech, medical device, and CRO organizations.

logo Quality Audits Regulatory Inspections Manufacturing & CMC Regulatory Affairs Professional Training Nonclinical Development Clinical Excellence
GxP Domains cGMP · GLP · GCP · GVP
Coverage Multiple Regulatory Jurisdictions Globally
25+ Years of Experienced Accomplished Professionals
Core Capabilities

End-to-End GxP Services for All Phases of Drug Product Development

Offered as standalone engagements or as a fully integrated program tailored to your pipeline, development phase and risk profile.

Quality systems and compliance

Quality Management Systems & Audits

Quality Management Systems & Audits

Extensive experience developing and implementing phase-appropriate quality systems following Quality by Design principles for pharmaceutical, biopharmaceutical, and medical device industries.

Quality Management System (QMS)
  • Develop client-specific QMS aligned to the unique needs of the program and phase of development
  • Analyze existing QMS, identify gaps, and provide phase-appropriate and resource-efficient solutions
Quality Operations
  • Investigation, impact assessment, and resolution of deviations, OOS results, non-conformities, and process failures
  • cGMP, GLP, GCP & GVP support
  • QMS remediation to address gaps based on guidance and regulatory requirements
GxP Audits & Supplier / Vendor Oversight
  • Develop, execute & manage risk-based audit programs
  • Internal, external, routine, and for-cause audits
  • Clinical sites (Phase I–IV), CROs, CMOs/CDMOs, TMF, CSR, system/process audits, API suppliers, packaging/labeling, distribution, laboratories
  • Vendor selection, qualification & oversight
Regulatory affairs strategy

Regulatory Affairs

Regulatory Affairs

End-to-end strategic and operational support for pharmaceutical/biopharmaceutical product lifecycle — from discovery through nonclinical, clinical, marketing authorization, and post-market commitments.

Global Regulatory Strategy & Support
  • Strategic & tactical regulatory assistance to meet global requirements across the product lifecycle
  • Experience with FDA, Health Canada, EMA & National Competent Authorities, MHRA, PMDA, TGA, ANVISA
Regulatory Gap Analysis & Filing Readiness
  • Review & assess current status for Pre-IND, IND, CTA, BLA/NDA, information requests, responses to deficiencies/hold
  • First-in-Human (FIH) readiness & BLA/NDA gap analysis
  • Readiness of meeting requests, designation requests, and response submissions
Regulatory Meeting Assistance
  • Lead/assist clients in internal preparation for regulatory meetings
  • Meeting participation, minutes, and post-meeting communication with regulatory agencies
Regulatory inspection readiness

Inspections

Inspections

Need-based solutions for preparation and management of regulatory inspections, and handling post-inspection communications across FDA, Health Canada, EMA, MHRA, PMDA, MFDS, NMPA, TGA, ANVISA, and CDSCO.

Preapproval Inspections · GCP, cGMP, GLP & PV Inspections · Clinical Sites / CRO / Vendor Inspections

Inspection Readiness & Preparation
  • Review & evaluate current status to identify gaps/risks and recommend remediation
  • Develop inspection readiness plan and timelines
  • Training of functional SMEs
  • Develop inspection playbook
  • Oversight of CRO/vendor inspection preparation
Mock Inspections
  • Plan & conduct mock inspections — simulate scenarios, interview SMEs, information requests
  • Provide detailed Mock Inspection Report identifying deficiencies
  • Collaborate with internal team to develop responses
Inspection Management
  • Manage / provide oversight for sponsor, clinical site, CRO/vendor inspections
  • Actively participate in all inspection activities to ensure smooth conduct and timely, accurate responses
Post-Inspection Communication
  • Collaborate to develop, prepare, and review responses to inspection deficiencies before submission
  • Manage corrective action implementation and track progress
GxP training programs

Training

Training

In-person or virtual training for cGMP, GLP, GCP & GVP compliance — tailored to your team's role, phase, and risk profile.

Training Programs
  • Annual GxP Training
  • Deviation & CAPA Management
  • Any topic related to GxP compliance in drug product development
Nonclinical preclinical research and study oversight

Nonclinical / Preclinical Development

Nonclinical / Preclinical Development

Planning and execution support for nonclinical development programs to generate reliable, robust data supporting product development and regulatory submissions.

Nonclinical Strategy
  • Regulatory positioning & early interaction strategy
  • Animal model selection & study design
  • FIH planning & identification of minimum requirements
Roadmap to First-in-Human (FIH) Trial
  • Detailed roadmap & timeline
  • Critical path identification
  • Resource planning
  • CRO / CDMO / vendor selection
Technical Writing & Study Oversight
  • Write/review study protocols, reports & regulatory submissions for accuracy, completeness, and compliance
  • Cross-functional CRO/vendor oversight, monitoring, and audits
CMC pharmaceutical development

CMC

CMC

Hands-on, phase-appropriate support for all aspects of CMC and drug product development under R&D and cGMP conditions. Develop, optimize, and validate effective, efficient, and cGMP-compliant manufacturing processes and analytical procedures.

Development & Validation Support
  • Facility assessment & design review for cGMP compliance
  • Manufacturing process development & validation support
  • Analytical method development & validation support
  • Development of manufacturing records/documentation
  • Product characterization and/or specifications
  • Process characterization & risk assessment
  • Technology transfer & scale-up
Clinical trial operations

Clinical

Clinical

Extensive expertise developing customised solutions to ensure the success of clinical trials — from document development through site close-out and quality assurance.

Clinical Document Development & Review
  • Clinical protocol, Informed Consent Form, Investigator's Brochure, Study Manuals, Pharmacy Manual, Statistical Analysis Plan, SAE Forms
Clinical Supplies Management
  • Develop/review product labels for regulatory compliance
  • Procedures for handling investigational products — shipping, storage, distribution, administration
  • Management of product complaints
Site Operations & Submissions
  • Clinical site qualification, initiation, routine monitoring, and close-out
  • Regulatory & ethics submissions
Quality & Data Oversight
  • Risk-based quality management & risk-based trial monitoring
  • Electronic Data Capture development and management oversight
  • Trial Master File set-up and management oversight
  • Clinical Quality Assurance
Global Reach

Integrated Global GxP Support across three continents

Standalone engagements or fully integrated cGMP–GCP–GLP–GVP programs — compliance activities tailored to your pipeline, development phase and risk profile.

North America

United States FDA

Canada Health Canada

Active Coverage

Europe & UK

European Union EMA

United Kingdom MHRA

Active Coverage

Asia-Pacific

Japan PMDA

South Korea MFDS

India CDSCO

China NMPA

Australia TGA

Active Coverage
Contact Us

Start an Inquiry

Let us hear from you. Tell us about your project needs so that we can provide customized solutions to align with your unique needs.

Your details are sent securely to GxP Compliance Group & are not shared with third parties.

Our Locations

Vancouver, BC, Canada +1 206-778-5159
Seattle, WA, USA 98012 +1 206-778-5159
Hyderabad, TG, India 500026 +91 98665 58804